These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33242513)

  • 21. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F; Valdés S; Tapia MJ; Esteva I; Ruiz de Adana MS; Almaraz MC; Morcillo S; García Fuentes E; Rodríguez F; Rojo-Martinez G
    Med Clin (Barc); 2012 Apr; 138(9):371-6. PubMed ID: 21939990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.
    Atayoglu AT; Inanc N; Başmisirli E; Çapar AG
    Prim Care Diabetes; 2020 Oct; 14(5):488-493. PubMed ID: 32029385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome.
    Meijnikman AS; De Block CEM; Verrijken A; Mertens I; Van Gaal LF
    Diabetol Metab Syndr; 2018; 10():12. PubMed ID: 29507612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year risk assessment for type 2 diabetes mellitus using the Finnish Diabetes Risk Score in family medicine.
    Savić S; Stanivuković S; Lakić B
    Med Glas (Zenica); 2020 Aug; 17(2):517-522. PubMed ID: 32662607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What if body fat percentage association with FINDRISC score leads to a better prediction of type 2 diabetes mellitus?
    Jurca-Simina IE; Jugănaru I; Iurciuc MŞ; Iurciuc S; Ungureanu E; Dobrescu AI; Chiriţă-Emandi A; Voinescu OR; Olariu IC; Puiu M; Georgescu D; Borugă VM
    Rom J Morphol Embryol; 2019; 60(1):205-210. PubMed ID: 31263846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
    Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
    Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Seven Type 2 Diabetes Mellitus Risk Scores in a Population-Based Cohort: The CoLaus Study.
    Kraege V; Fabecic J; Marques-Vidal P; Waeber G; Méan M
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31781764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Finnish Diabetes Risk Score to predict type 2 diabetes mellitus in a Colombian population: A longitudinal observational study.
    Gomez-Arbelaez D; Alvarado-Jurado L; Ayala-Castillo M; Forero-Naranjo L; Camacho PA; Lopez-Jaramillo P
    World J Diabetes; 2015 Dec; 6(17):1337-44. PubMed ID: 26675051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J; Stancáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3858-62. PubMed ID: 20463095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study.
    Nieto-Martinez R; Barengo NC; Restrepo M; Grinspan A; Assefi A; Mechanick JI
    Front Endocrinol (Lausanne); 2023; 14():1188784. PubMed ID: 37435487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality.
    Silventoinen K; Pankow J; Lindström J; Jousilahti P; Hu G; Tuomilehto J
    Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):451-8. PubMed ID: 16210931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
    Suvitaival T; Bondia-Pons I; Yetukuri L; Pöhö P; Nolan JJ; Hyötyläinen T; Kuusisto J; Orešič M
    Metabolism; 2018 Jan; 78():1-12. PubMed ID: 28941595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The FINDRISC questionnaire capacity to predict diabetes mellitus II, arterial hypertension and comorbidity in women from low-and-middle-income countries.
    Rodríguez MG; Saldaña MR; Leyva JMA; Rojas RM; Molina-Recio G
    Health Care Women Int; 2020 Feb; 41(2):205-226. PubMed ID: 31825753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte count, C-reactive protein level and incidence risk of type 2 diabetes among non-smoking adults: A longitudinal finding over 12 years from the Korean Genome and Epidemiology Study.
    Cho AR; Lee JH; Lee HS; Lee YJ
    Prim Care Diabetes; 2021 Apr; 15(2):385-390. PubMed ID: 33281100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthyroxinemia is positively associated with prevalent and incident type 2 diabetes mellitus in two population-based samples from Northeast Germany and Denmark.
    Ittermann T; Schipf S; Dörr M; Thuesen BH; Jørgensen T; Völzke H; Markus MRP
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):173-179. PubMed ID: 29239740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: From the CORDIOPREV study.
    Camargo A; Jimenez-Lucena R; Alcala-Diaz JF; Rangel-Zuñiga OA; Garcia-Carpintero S; Lopez-Moreno J; Blanco-Rojo R; Delgado-Lista J; Perez-Martinez P; van Ommen B; Malagon MM; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
    Clin Nutr; 2019 Apr; 38(2):529-538. PubMed ID: 29685478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.